


| Key | % Net Assets | 
|---|---|
| 5.1% | |
| 5.0% | |
| 5.0% | |
| 4.9% | |
| 80% | 
| Name | % Net Assets | 
|---|---|
| Vodafone Group | 5.1% | 
| GLAXOSMITHKLINE | 5.0% | 
| Astrazeneca | 5.0% | 
| Unilever | 4.9% | 
| British American Tobacco | 4.6% | 
| BP | 4.2% | 
| Royal Dutch Shell B | 4.1% | 
| Centrica | 3.9% | 
| BT group | 3.7% | 
| BG Group | 3.4% | 
No asset data available.
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | n/a | 
|---|---|
| Fund Manager | Daniel Roberts | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | 1000 | 
| Additional | 250 | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | n/a | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research